177 related articles for article (PubMed ID: 22407414)
1. Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.
Sicouri S; Blazek J; Belardinelli L; Antzelevitch C
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):371-9. PubMed ID: 22407414
[TBL] [Abstract][Full Text] [Related]
2. Effect of autonomic influences to induce triggered activity in muscular sleeves extending into the coronary sinus of the canine heart and its suppression by ranolazine.
Sicouri S; Belardinelli L; Antzelevitch C
J Cardiovasc Electrophysiol; 2019 Feb; 30(2):230-238. PubMed ID: 30302862
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.
Sicouri S; Glass A; Belardinelli L; Antzelevitch C
Heart Rhythm; 2008 Jul; 5(7):1019-26. PubMed ID: 18598958
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967.
Sicouri S; Belardinelli L; Antzelevitch C
Heart Rhythm; 2013 Jul; 10(7):1036-43. PubMed ID: 23524321
[TBL] [Abstract][Full Text] [Related]
5. Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.
Sicouri S; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
Heart Rhythm; 2012 Mar; 9(3):422-9. PubMed ID: 22019863
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves.
Sicouri S; Carlsson L; Antzelevitch C
J Pharmacol Exp Ther; 2010 Jul; 334(1):255-9. PubMed ID: 20360353
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations.
Sicouri S; Gianetti B; Zygmunt AC; Cordeiro JM; Antzelevitch C
J Am Coll Cardiol; 2011 Feb; 57(8):986-93. PubMed ID: 21329846
[TBL] [Abstract][Full Text] [Related]
8. Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria.
Sicouri S; Burashnikov A; Belardinelli L; Antzelevitch C
Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):88-95. PubMed ID: 19952329
[TBL] [Abstract][Full Text] [Related]
9. Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparations.
Sicouri S; Belardinelli L; Carlsson L; Antzelevitch C
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):803-10. PubMed ID: 19298559
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Vein Sleeves as a Pharmacologic Model for the Study of Atrial Fibrillation.
Sicouri S; Antzelevitch C
Electrofisiol Arritm; 2010 Oct; 3(4):108-113. PubMed ID: 24999375
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic effects of losartan and enalapril in canine pulmonary vein sleeve preparations.
Sicouri S; Cordeiro JM; Talarico M; Antzelevitch C
J Cardiovasc Electrophysiol; 2011 Jun; 22(6):698-705. PubMed ID: 21159010
[TBL] [Abstract][Full Text] [Related]
12. Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.
Burashnikov A; Belardinelli L; Antzelevitch C
J Pharmacol Exp Ther; 2012 Jan; 340(1):161-8. PubMed ID: 22005044
[TBL] [Abstract][Full Text] [Related]
13. ATX-II-induced pulmonary vein arrhythmogenesis related to atrial fibrillation and long QT syndrome.
Lu YY; Cheng CC; Chen YC; Chen SA; Chen YJ
Eur J Clin Invest; 2012 Aug; 42(8):823-31. PubMed ID: 22339387
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiology and arrhythmogenic activity of single cardiomyocytes from canine superior vena cava.
Chen YJ; Chen YC; Yeh HI; Lin CI; Chen SA
Circulation; 2002 Jun; 105(22):2679-85. PubMed ID: 12045176
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.
Burashnikov A; Sicouri S; Di Diego JM; Belardinelli L; Antzelevitch C
J Am Coll Cardiol; 2010 Oct; 56(15):1216-24. PubMed ID: 20883928
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.
Antzelevitch C; Belardinelli L; Zygmunt AC; Burashnikov A; Di Diego JM; Fish JM; Cordeiro JM; Thomas G
Circulation; 2004 Aug; 110(8):904-10. PubMed ID: 15302796
[TBL] [Abstract][Full Text] [Related]
17. Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
Burashnikov A; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):400-8. PubMed ID: 22322366
[TBL] [Abstract][Full Text] [Related]
18. Ectopies from the superior vena cava after pulmonary vein isolation in patients with atrial fibrillation.
Sugimura S; Kurita T; Kaitani K; Yasuoka R; Miyazaki S
Heart Vessels; 2016 Sep; 31(9):1562-9. PubMed ID: 26518692
[TBL] [Abstract][Full Text] [Related]
19. Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations.
Szél T; Koncz I; Jost N; Baczkó I; Husti Z; Virág L; Bussek A; Wettwer E; Ravens U; Papp JG; Varró A
Eur J Pharmacol; 2011 Jul; 662(1-3):31-9. PubMed ID: 21550338
[TBL] [Abstract][Full Text] [Related]
20. Structural relation between the superior vena cava and pulmonary veins in patients with atrial fibrillation.
Yoshida K; Baba M; Hasebe H; Shinoda Y; Harunari T; Ebine M; Uehara Y; Watabe H; Takeyasu N; Horigome H; Nogami A; Ieda M
Heart Vessels; 2019 Dec; 34(12):2052-2058. PubMed ID: 31114962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
